{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:03:49Z","timestamp":1768251829670,"version":"3.49.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Beta-catenin (BC) mutations are associated with a high risk of recurrence in otherwise low-grade, early-stage uterine endometrioid adenocarcinomas. Recent literature suggests nuclear BC expression by immunohistochemistry is highly sensitive and specific for BC mutations. The significance of BC expression in endometrioid intraepithelial neoplasia (EIN\/atypical hyperplasia) and its relationship to altered differentiation patterns in EIN has yet to be fully explored. Cases meeting current diagnostic criteria for EIN based on H&amp;E examination were obtained from 2 institutions (years 1999\u20132014). Patterns of altered differentiation (eg, tubal, squamous morular metaplasia, mucinous, secretory) were noted. Representative blocks were stained for BC, and expression patterns recorded. Follow-up and demographic data was obtained from the electronic medical record. Ninety-six cases were included (84 biopsies, 12 hysterectomies). BC nuclear expression was identified in 41 cases (42.7%), with 33 of 41 demonstrating foci of nonmorular BC staining. BC staining in any component of EIN was not significantly associated with the presence of carcinoma on subsequent hysterectomy (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.79). When restricting to nonmorular BC, the results were the same (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.56). Cases with tubal differentiation were significantly less likely to demonstrate nonmorular BC than cases with no specific pattern of differentiation (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). EIN frequently demonstrates BC nuclear positivity, especially in cases without tubal differentiation. BC nuclear expression in EIN does not appear to be associated with an increased likelihood of carcinoma on subsequent hysterectomy. Our results do not support routine use of BC immunohistochemistry as a prognostic biomarker in cases of EIN.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000695","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:00:24Z","timestamp":1599411624000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy"],"prefix":"10.1097","volume":"40","author":[{"given":"Martha F.","family":"Wright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Fitzlaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Autumn","family":"Wyeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Zaragoza-Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna B.","family":"Podoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn C.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/B-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","article-title":"Beta-catenin signaling and cancer","volume":"21","author":"Morin","year":"1999","journal-title":"Bioessays"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1038\/sj.onc.1203245","article-title":"Mechanism and function of signal transduction by the Wnt\/B-catenin and Wnt\/Ca2+ pathways","volume":"18","author":"Miller","year":"1999","journal-title":"Oncogene"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.addr.2010.09.012","article-title":"The Wnt signaling pathway in cellular proliferation and differentiation: a tale of two coactivators","volume":"62","author":"Teo","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/hupa.2002.30723","article-title":"CTNNB1 mutations and \u03b2-catenin expression in endometrial carcinomas","volume":"33","author":"Machin","year":"2002","journal-title":"Hum Pathol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of B-catenin-Tcf signaling in colon cancer by mutations in B-catenin or APC","volume":"275","author":"Morin","year":"1997","journal-title":"Science"},{"key":"R8-20250802","first-page":"1344","article-title":"Mutations in the B-catenin gene (CTNNB1) in endometrioid ovarian carcinomas","volume":"58","author":"Palacios","year":"1998","journal-title":"Cancer Res"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/sj.onc.1201462","article-title":"Induction of a B-catenin-LEF-1 complex by wnt-1 and transforming mutants of B-catenin","volume":"15","author":"Porfiri","year":"1997","journal-title":"Oncogene"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.275.5307.1790","article-title":"Stabilization of B-catenin bygenetic defects in melanoma cell lines","volume":"275","author":"Rubinfeld","year":"1997","journal-title":"Science"},{"key":"R11-20250802","first-page":"3526","article-title":"Beta-catenin mutation in carcinoma of the uterine endometrium","volume":"58","author":"Fukuchi","year":"1998","journal-title":"Cancer Res"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","article-title":"Exon 3 mutations of CTNNB1 drive tumorigenesis: a review","volume":"9","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear B-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"pii:dju245","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PGP.0000000000000583","article-title":"Clinicopathologic and immunohistochemical correlates of CTNNB1 mutated endometrial endometrioid carcinoma","volume":"39","author":"Costigan","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod Pathol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2014.06.010","article-title":"B-catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers","volume":"134","author":"Myers","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s007950200001","article-title":"Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia","volume":"35","author":"Ashihara","year":"2002","journal-title":"Med Electron Microsc"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/modpathol.2009.45","article-title":"Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin","volume":"22","author":"Liao","year":"2009","journal-title":"Mod Pathol"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/path.1310","article-title":"Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia","volume":"199","author":"Moreno-Bueno","year":"2003","journal-title":"J Pathol"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.anndiagpath.2006.06.009","article-title":"Immunohistochemical expression of PTEN and B-catenin for endometrial intraepithelial neoplasia in Japanese women","volume":"11","author":"Norimatsu","year":"2007","journal-title":"Ann Diagn Pathol"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1581","article-title":"Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis","volume":"84","author":"Saegusa","year":"2001","journal-title":"Br J Cancer"},{"key":"R24-20250802","first-page":"699","article-title":"Nuclear expression of B-catenin in endometrial hyperplasia as a marker of premalignancy","volume":"127","author":"Travaglino","year":"2019","journal-title":"APIMS"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fonc.2019.00123","article-title":"Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions in Chinese patients by high-depth next generation sequencing","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.semdp.2010.09.007","article-title":"Endometrial intraepithelial neoplasia","volume":"27","author":"Jarboe","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.humpath.2017.07.003","article-title":"Clonal evolution in paired endometrial intraepithelial neoplasia\/atypical hyperplasia and endometrioid adenocarcinoma","volume":"67","author":"Russo","year":"2017","journal-title":"Hum Pathol"},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PGP.0000000000000549","article-title":"PI3K pathway effectors pAKT and FOXO1 as novel markers of endometrioid intraepithelial neoplasia","volume":"38","author":"Strickland","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"R32-20250802","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1309\/4MGM-FMRC-6AWK-YQY2","article-title":"Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues","volume":"113","author":"Faquin","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R33-20250802","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/PGP.0000000000000557","article-title":"Mismatch repair protein expression in endometrioid intraepithelial neoplasia\/atypical hyperplasia: should we screen for Lynch syndrome in precancerous lesions?","volume":"38","author":"Lucas","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R34-20250802","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.pas.0000171001.87599.e2","article-title":"Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules)","volume":"29","author":"Brachtel","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R35-20250802","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1309\/AJCP8OMLT7KDWLMF","article-title":"Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia","volume":"138","author":"Quick","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R36-20250802","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/modpathol.2011.220","article-title":"Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists","volume":"25","author":"Usubutun","year":"2012","journal-title":"Mod Pathol"},{"key":"R37-20250802","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/cncr.21058","article-title":"The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system","volume":"103","author":"Baak","year":"2005","journal-title":"Cancer"},{"key":"R38-20250802","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5858\/arpa.2012-0709-RA","article-title":"Endometrial intraepithelial neoplasia","volume":"138","author":"Owings","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R39-20250802","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e31821d78af","article-title":"Endometrial intraepithelial neoplasia: clinical correlates and outcomes","volume":"118","author":"Semere","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R40-20250802","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/modpathol.2008.146","article-title":"Squamous morules are functionally inert elements of premalignant endometrial neoplasia","volume":"22","author":"Lin","year":"2009","journal-title":"Mod Pathol"},{"key":"R41-20250802","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jcp.2010.085555","article-title":"Endometrial metaplasias and reactive changes: a spectrum of altered differentiation","volume":"64","author":"Nicolae","year":"2011","journal-title":"J Clin Pathol"},{"key":"R42-20250802","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","article-title":"Abnormalities of the APC\/beta-catenin pathway in endometrial cancer","volume":"21","author":"Moreno-Bueno","year":"2002","journal-title":"Oncogene"},{"key":"R43-20250802","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/aqy178","article-title":"Immunohistochemical nuclear expression of B-catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial cancer","volume":"151","author":"Travaglino","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"R44-20250802","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2559.2008.03083.x","article-title":"Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2","volume":"53","author":"Houghton","year":"2008","journal-title":"Histopathology"},{"key":"R45-20250802","doi-asserted-by":"crossref","first-page":"R647","DOI":"10.1530\/ERC-18-0112","article-title":"An update of Wnt signaling in endometrial cancer and its potential as a therapeutic target","volume":"25","author":"Coopes","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"R46-20250802","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-2744(199907)25:3<207::AID-MC7>3.0.CO;2-4","article-title":"Nuclear localization of beta-catenin in normal and carcinogenic endometrium","volume":"25","author":"Nei","year":"1999","journal-title":"Mol Carcinog"},{"key":"R47-20250802","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.4160","article-title":"Alterations in Wnt-B-catenin and Pten signaling play distinct roles in endometrial cancer initiation and progression","volume":"230","author":"Van der Zee","year":"2013","journal-title":"J Pathol"},{"key":"R48-20250802","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.2008.03104.x","article-title":"Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change","volume":"53","author":"Carlson","year":"2008","journal-title":"Histopathology"},{"key":"R49-20250802","doi-asserted-by":"crossref","first-page":"674","DOI":"10.18632\/oncotarget.201","article-title":"Wnt\/B-catenin and sex hormone signaling in endometrial homeostasis and cancer","volume":"1","author":"Wang","year":"2010","journal-title":"Oncotarget"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:25Z","timestamp":1754161585000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000695","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,4]]}}}